筛查漏诊的乳腺癌:回顾性审视还是失误?
研究回顾性分析1223例筛查检出癌和1007例间期癌,按共识复审分为漏诊或真阴性,评估既往筛查时放射科医生的判读评分与漏诊风险的关联。多数癌症在诊断前筛查时被判读为阴性;既往筛查阳性判读与漏诊筛查检出癌或间期癌风险升高相关。
要点
- 筛查检出癌中,漏诊癌31%在既往筛查有不一致或一致阳性判读,真阴性癌仅10%。
- 间期癌中,漏诊癌21%在既往筛查有阳性判读,真阴性癌仅8%。
- 以一致阴性为参照,不一致判读后漏诊筛查检出癌的年龄调整OR为3.8(95%CI 2.6-5.4)。
核心结论
- 多数癌症在诊断前筛查时被判读为阴性;既往筛查阳性判读与漏诊筛查检出癌或间期癌风险升高相关。
研究设计与样本
- 回顾性研究纳入1223例筛查检出癌和1007例间期癌,经知情共识复审分类为漏诊或真阴性;所有既往筛查检查由两名放射科医生独立评分1-5分。
关键影像表现/征象
- 不对称是既往筛查时所有癌症的主要乳腺X线特征,但一致阳性判读的筛查检出癌以肿块为主。
- 组织病理学特征与判读之间无统计学差异。
诊断标准与关键数值
- 两名放射科医生均评1分定义为一致阴性,一名评≥2分为不一致,两名均评≥2分为一致阳性。
- 筛查检出癌中,漏诊癌31%、真阴性癌10%在既往筛查为不一致或一致阳性判读。
- 间期癌中,漏诊癌21%、真阴性癌8%在既往筛查为不一致或一致阳性判读。
- 以一致阴性为参照,漏诊筛查检出癌年龄调整OR:不一致判读3.8(95%CI 2.6-5.4),一致阳性判读5.5(95%CI 3.2-9.5)。
- 漏诊间期癌年龄调整OR:不一致判读3.0(95%CI 2.0-4.5),一致阳性判读6.3(95%CI 2.3-17.5)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To investigate radiologists' interpretation scores of screening mammograms prior to diagnosis of screen-detected and interval breast cancers retrospectively classified as missed or true negative.
METHODS: We included data on radiologists' interpretation scores at screening prior to diagnosis for 1223 screen-detected and 1007 interval cancer cases classified as missed or true negative in an informed consensus-based review. All prior screening examinations were independently scored 1-5 by two radiologists; score 1 by both was considered concordant negative, score ≥ 2 by one radiologist discordant, and score ≥ 2 by both concordant positive. We analyzed associations between interpretation, review categories, mammographic features and histopathological findings using descriptive statistics and logistic regression.
RESULTS: Among screen-detected cancers, 31% of missed and 10% of true negative cancers had discordant or concordant positive interpretation at prior screening. The corresponding percentages for interval cancer were 21% and 8%. Age-adjusted odds ratio (OR) and 95% confidence interval (CI) for missed screen-detected cancer was 3.8 (95% CI: 2.6-5.4) after discordant and 5.5 (95% CI: 3.2-9.5) after concordant positive interpretation, using concordant negative as reference. Corresponding ORs for missed interval cancer were 3.0 (95% CI: 2.0-4.5) for discordant and 6.3 (95% CI: 2.3-17.5) for concordant positive interpretation. Asymmetry was the dominating mammographic feature at prior screening for all, except concordant positive screen-detected cancers where a mass dominated. Histopathological characteristics did not vary statistically with interpretation.
CONCLUSIONS: Most cancers were interpreted negatively at screening prior to diagnosis. Increased risk for missed screen-detected or interval cancer was observed after positive interpretation at prior screening.
引用
- Hovda, Larsen, Romundstad, et al. Breast cancer missed at screening; hindsight or mistakes? Eur J Radiol. 2023. PMID: 37311339. doi:10.1016/j.ejrad.2023.110913
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。